Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal insulin for prevention of type 1 diabetes (INITII)
NCT00336674Phase 2Completed
- Sponsor
- Melbourne Health
- Start
- Dec 2006
- Primary completion
- Nov 2019
- Countries
- 2
01
Overview
A Phase 2 trial of Generex Oral-lyn in type 1 diabetes mellitus (T1D), sponsored by Melbourne Health. Started Dec 2006; status: completed.
02
Drugs
Generex Oral-lyn
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00336674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00336674.